Considerable practice variation among surgeons in selecting patients for radical prostatectomy

This article originally appeared here.
Considerable Surgeon-Level Variation in Radical Prostatectomy
Considerable Surgeon-Level Variation in Radical Prostatectomy

(HealthDay News) -- Considerable practice variation exists among surgeons at a high-volume academic center when selecting patients with prostate cancer to undergo radical prostatectomy, according to a study published in the March issue of The Journal of Urology.

Hiten D. Patel, M.D., M.P.H., from Johns Hopkins Medical Institutions in Baltimore, and colleagues examined practice variability among urologists practicing at a high-volume academic center. The authors examined the percent of patients at low risk treated with radical prostatectomy in a given year and assessed the proportion of variance due to surgeon and temporal effects.

The researchers found that the percent of low-risk patients treated with prostatectomy increased 3.49 percent per year from 1991 to 2001 and decreased by 1.73 percent annually from 2001 to 2013. From 1991 to 2001, in a given year, greater surgeon experience correlated with a higher percent of patients at low risk treated with prostatectomy (0.46 percent per year of experience). High-volume surgeons operated on a greater percent of low-risk patients (3.54 percent). In a given year, surgeon level and temporal effects accounted for 24 and 70 percent, respectively, of the variance in the percent of patients at low risk treated with radical prostatectomy.

"In addition to patient decision support tools, publicly reporting individual practice patterns at the provider level could decrease the overtreatment of low-risk prostate cancer," the authors write.

Abstract
Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs